Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
about
Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues.Carcinomas of an unknown primary origin--diagnosis and treatment.Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.New agents in relapsed/refractory Hodgkin's lymphoma.Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma.A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.Autologous Stem Cell Transplantation After Second Line Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma.Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF.Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma.
P2860
Q37053190-515A5155-DB3F-4744-BD3B-20DE1068CF13Q37952110-20FD7D84-EA73-4DB4-B8A4-F70BF53F4626Q40392451-207C13CD-FA86-43A9-940F-0A9121DF4250Q41500227-44B98DEE-F483-4EAE-93F0-E3623DA3C689Q42375641-E6AD79C2-1E3F-4E45-B088-4329732A3091Q45204161-440F2215-DBD2-465B-B790-C1DAE229FCF8Q46813560-2D088526-7E5F-4F30-8DB2-009F00B9F934Q47562175-9A54367A-E5BD-49EC-89AD-F70801437AA3Q47563022-8FB7B88F-F833-45F3-AAC9-718DFCEA4037Q52603856-AC32FEA2-78FD-4762-A956-C89BA50A1766Q52852967-873C584B-0FCD-47BA-A4C8-30C50F9CAAEBQ53571230-1E91700D-21EB-4FAE-BA2D-51145C300D02
P2860
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@ast
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@en
type
label
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@ast
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@en
prefLabel
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@ast
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@en
P2093
P356
P1433
P1476
Outpatient-based ifosfamide, c ...... ymphoma and Hodgkin's disease.
@en
P2093
D Gottlieb
K F Bradstock
M S Hertzberg
P356
10.1093/ANNONC/MDG703
P478
14 Suppl 1
P577
2003-01-01T00:00:00Z